menu
    • menu

    Company profile for Pharm-Olam

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Pharm-Olam, is an award-winning CRO with a history that runs back 25 years to its founding in 1994, by Dr. Zev Munk and his co-founder and business partner, Eugene Barg. Dr. Munk was a practicing clinician focused on allergy and immunology, serving patients in Houston, Texas. He was conducting clinical research for years and knew there was a better way to support sites, patients and the conduct of clinical research. As a compa...
    Pharm-Olam, is an award-winning CRO with a history that runs back 25 years to its founding in 1994, by Dr. Zev Munk and his co-founder and business partner, Eugene Barg. Dr. Munk was a practicing clinician focused on allergy and immunology, serving patients in Houston, Texas. He was conducting clinical research for years and knew there was a better way to support sites, patients and the conduct of clinical research. As a compassionate health care provider, he recognized the need for a flexible and innovative CRO that could help deliver solutions to the challenges commonly encountered during the investigational product development process.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Pharm-OlamUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    450 N. Sam Houston Parkway E., | Suite 250 Houston, Texas 77060
    Telephone
    Telephone
    +1 (713) 559-7900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.pharm-olam.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/pharm-olam-llc/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Pharm_Olam

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pharm-Olam enrolling UK volunteers into a pivotal PhIII COVID-19 vaccine study
    Pharm-Olam enrolling UK volunteers into a pivotal PhIII COVID-19 vaccine study

    20 May 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/pharm-olam-is-now-enrolling-uk-volunteers-into-a-pivotal-phase-iii-covid-19-vaccine-study-301294876.html#:~:text=HOUSTON%2C%20May%2020%2C%202021%20%2F,III%20COVID%2D19%20vaccine%20study.

    PRNEWSWIRE
    20 May 2021
    Share Share
    Pharm-Olam enrolling UK volunteers into a pivotal PhIII COVID-19 vaccine study
    Pharm-Olam enrolling UK volunteers into a pivotal PhIII COVID-19 vaccine study

    20 May 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/pharm-olam-is-now-enrolling-uk-volunteers-into-a-pivotal-phase-iii-covid-19-vaccine-study-301294876.html#:~:text=HOUSTON%2C%20May%2020%2C%202021%20%2F,III%20COVID%2D19%20vaccine%20study.

    PRNEWSWIRE
    20 May 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search